基本信息
浏览量:45
职业迁徙
个人简介
Dr. John M. Beals worked for 31+ years for Eli Lilly and Company, achieving the ultimate distinction of Distinguished Research Fellow, the highest level on the technical track. Using his formal training in biology, chemistry, and protein engineering, Dr. Beals led efforts to integrate a diverse set of requirements required for making world-class protein therapeutics, which included, but was not limited to, efficacy, disposition, formulation, manufacture, and drug delivery. His creation and leadership of a Discovery-based protein optimization team, coupled with the collaboration and acquisition of Applied Molecular Evolution, Inc., created a Discovery research interface for all therapeutic biology teams, the ADME organization, as well as the downstream Development and Manufacturing organizations. This optimization team exploited protein engineering strategies to deliver not only biologics to meet functional requirements, but also addressed downstream formulation, manufacturing, and delivery system requirements to increase the probability of commercial success. During his tenure in Bioproducts Development and the Biotechnology Discovery Research Divisions, Dr. Beals influenced and contributed to the launch of eight commercial drugs and numerous novel clinical candidates, published 46 peer-reviewed papers, authored 11 book chapters, issued four patents, presented numerous external talks, and assisted in the promotion of numerous scientists. He currently is the founder of Hiphaestian Consulting LLC, which specializes in advising companies on the creation, formulation, manufacture, and delivery of protein therapeutics.
研究兴趣
论文共 56 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Journal of biomedical opticsno. 11 (2023): 116002-116002
Advanced Scienceno. 28 (2022): e2202907-e2202907
crossref(2022)
Springer eBookspp.81-93, (2022)
biorxiv(2022)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn